Although CAR T cell therapy has been approved by regulatory agencies like the FDA for certain cancers, it is currently available at a limited number of specialized centers. The treatment is also very expensive, which can be a barrier for many patients. Efforts are ongoing to make CAR T cell therapy more widely accessible and affordable.
